Jeffrey A Zonder Selected Research

filanesib

1/2022	Filanesib plus bortezomib and dexamethasone in relapsed/refractory t(11;14) and 1q21 gain multiple myeloma.
12/2017	A Phase 1 and 2 study of Filanesib alone and in combination with low-dose dexamethasone in relapsed/refractory multiple myeloma.
11/2016	A phase 1 dose-escalation study of filanesib plus bortezomib and dexamethasone in patients with recurrent/refractory multiple myeloma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jeffrey A Zonder Research Topics

Disease

26	Multiple Myeloma 01/2022 - 07/2006
5	Disease Progression 01/2022 - 06/2003
5	Immunoglobulin Light-chain Amyloidosis 01/2021 - 01/2017
4	Neoplasms (Cancer) 12/2016 - 12/2006
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 09/2006 - 01/2003
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2021 - 01/2012
2	Amyloidosis 01/2021 - 01/2020
2	Infections 01/2021 - 10/2020
2	Blast Crisis (Blast Phase) 09/2006 - 01/2003
1	Lymphopenia (Lymphocytopenia) 01/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Diarrhea 01/2021
1	Cardiomyopathies (Cardiomyopathy) 01/2021
1	Heart Failure 01/2021
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2021
1	COVID-19 10/2020
1	Vomiting 01/2020
1	Fatigue 01/2020
1	Nausea 01/2020
1	Compression Fractures (Compression Fracture) 01/2019
1	Pain (Aches) 01/2019
1	Anemia 01/2018
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 02/2017
1	Lymphoma (Lymphomas) 01/2014
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2012
1	Neutropenia 12/2010
1	Thrombocytopenia (Thrombopenia) 08/2010
1	Hematologic Neoplasms (Hematological Malignancy) 07/2009
1	Thromboembolism 12/2006
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 09/2006
1	Philadelphia Chromosome 09/2006

Drug/Important Bio-Agent (IBA)

17	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022 - 07/2006
12	Bortezomib (Velcade)FDA Link 01/2022 - 07/2009
9	Lenalidomide (CC 5013)FDA Link 01/2022 - 07/2006
6	Proteasome InhibitorsIBA 01/2021 - 07/2009
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2014
3	filanesibIBA 01/2022 - 11/2016
3	ixazomibIBA 07/2021 - 01/2014
3	selinexorIBA 01/2021 - 01/2019
3	carfilzomibIBA 10/2020 - 01/2017
3	Bendamustine Hydrochloride FDA Link 01/2020 - 05/2012
3	Proteasome Endopeptidase Complex (Proteasome)IBA 02/2017 - 07/2009
3	Pharmaceutical PreparationsIBA 01/2017 - 01/2003
3	Imatinib Mesylate (Gleevec)FDA Link 09/2006 - 01/2003
2	KinesinsIBA 01/2022 - 11/2016
2	elotuzumabIBA 01/2021 - 07/2012
2	Immunomodulating AgentsIBA 01/2021 - 07/2009
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021 - 01/2018
2	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 01/2021 - 01/2017
2	Melphalan (Alkeran)FDA LinkGeneric 01/2012 - 07/2009
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2010 - 07/2006
2	Thalidomide (Thalomid)FDA Link 07/2009 - 12/2006
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 09/2006 - 01/2003
1	Circular RNAIBA 11/2021
1	Amyloid (Amyloid Fibrils)IBA 01/2021
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021
1	daratumumabIBA 01/2021
1	ParaproteinsIBA 12/2020
1	Immunoglobulins (Immunoglobulin)IBA 12/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 12/2016
1	BIW-8962IBA 01/2016
1	Monoclonal AntibodiesIBA 01/2016
1	G(M2) Ganglioside (Ganglioside GM2)IBA 01/2016
1	GangliosidesIBA 01/2016
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2015
1	palbociclibIBA 01/2015
1	Sorafenib (BAY 43-9006)FDA Link 10/2014
1	UbiquitinIBA 01/2014
1	delanzomibIBA 01/2014
1	marizomibIBA 01/2014
1	Ligases (Synthetase)IBA 01/2014
1	Deubiquitinating EnzymesIBA 01/2014
1	ONX 0912IBA 01/2014
1	Prednisone (Sone)FDA LinkGeneric 07/2009
1	TeaIBA 07/2009
1	PolyphenolsIBA 07/2009
1	GenisteinIBA 07/2009
1	CurcuminIBA 07/2009
1	Cytotoxins (Cytolysins)IBA 07/2009
1	GlucocorticoidsIBA 07/2009
1	IsoflavonesIBA 07/2009
1	Tyrosine Kinase InhibitorsIBA 06/2003
1	bcr-abl Fusion ProteinsIBA 06/2003
1	Interferon-alpha (Interferon Alfa)IBA 01/2003

Therapy/Procedure

13	Therapeutics 01/2022 - 07/2009
4	Stem Cell Transplantation 01/2022 - 05/2016
2	Drug Therapy (Chemotherapy) 01/2012 - 07/2009
1	Transplantation 01/2022
1	Vertebroplasty 01/2019
1	Kyphoplasty 01/2019
1	Drug Tapering 08/2010
1	Autologous Transplantation 07/2009
1	Radiotherapy 07/2009
1	Investigational Therapies (Experimental Therapy) 06/2003